Ruggiero Mascolo

Dr. Ruggiero Mascolo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2023 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
APAnna Maria Pisacreta
Anna Maria Pisacreta
RMRuggiero Mascolo
Ruggiero Mascolo
MNMariangela Nivuori
Mariangela Nivuori
CDCostanza Caccia Dominioni
Costanza Caccia Dominioni
CGClaudia Gabiati
Claudia Gabiati
ABAntonio Brucato
Antonio Brucato


11 January 2025 in Current Cardiology Reports
Verified
Journal Article
Open access
PDF file
RMRuggiero Mascolo
Ruggiero Mascolo
EBEmanuele Bizzi
Emanuele Bizzi
MMMartina Martelli
Martina Martelli
CFChiara Facoetti
Chiara Facoetti
GCGiulia Colazzo
Giulia Colazzo
ABAntonio Brucato
Antonio Brucato
Purpose of Review: To outline the latest discoveries regarding the utility and reliability of serum biomarkers in idiopathic recurrent acute pericarditis (IRAP), considering recent findings on its pathogenesis. The study highlights the predictive role of these biomarkers in potential short- (cardiac tamponade, recurrences) and long-term complications (constrictive pericarditis, death). Recent Findings: The pathogenesis of pericarditis has been better defined in recent years, focusing on the autoinflammatory pathway. New studies have demonstrated the pivotal role of the classical inflammatory biomarkers in distinguishing pericarditis phenotypes (high-grade vs. low-grade inflammation) and in defining outcomes of this condition. Summary: Pericarditis involves intense inflammatory activity, which causes elevation of different markers, such as C-reactive protein, erythrocyte sedimentation rate, neutrophils and platelets, serum amyloid A and D-Dimer. Conversely, lymphocytes are often reduced, as well as hemoglobin during the acute phase. Cardiac troponins T and I are elevated in up to 30% of cases. A Biomarker for CRP-negative cases is needed. Other markers have been proposed for diagnosis and prognosis in IRAP, such as anti-heart antibodies and anti-intercalated disk antibodies, but we need further studies to validate them.

19 March 2025 in European Journal of Internal Medicine
Verified
Journal Article
Open access
RMRuggiero Mascolo
Ruggiero Mascolo
Maddalena Alessandra WuMaddalena Alessandra Wu
Maddalena Alessandra Wu
SBSilvia Berra
Silvia Berra
MVMatteo Vidali
Matteo Vidali
MPMassimo Pancrazi
Massimo Pancrazi
ABAntonio Brucato
Antonio Brucato
Differences in recurrent pericarditis with normal vs. elevated C-reactive protein (CRP) are unknown. We studied 448 patients with recurrent or incessant pericarditis. CRP levels <10 mg/L were considered normal. Forty-one patients with normal CRP were tested for interleukin 6 (IL-6), serum amyloid A (SAA) and soluble urokinase plasminogen activator receptor (suPAR). Among the cohort (median age 43 years, 48.4% females), 336 patients (75%) had elevated CRP, while 112 (25%) had normal levels. CRP-negative patients were younger (38.6 vs. 43.5 years, p=0.007) and predominantly female (67.9% vs. 42.0%, p<0.001). They presented less often with fever (23.2% vs. 74.1%, p<0.001), pleural involvement (7.1% vs. 61.6% p<0.001), and neutrophilic leucocytosis (WBC 6760 vs. 12315/µL, p<0.001). Pericardiocentesis was performed rarely in CRP-negative patients (2.7% vs. 13.4%, p=0.001). Recurrence rates were similar (5.4 vs. 5.5/100 months-patient, p=0.918). Among CRP-negative patients, 53 (47.3%) had an incessant course characterized by persistent symptoms (pain and tachycardia); abnormal instrumental findings included ECG changes (28.6%), mild pericardial effusion (86.6%), and cardiac magnetic resonance evidence of effusion/oedema/late gadolinium enhancement (43.7%). Anakinra was administered to 48 CRP-positive (14.3%) and 10 CRP-negative patients (8.9%), leading to good responses with discontinuation of NSAIDs and corticosteroids in 39/48 (81.2%) and 5/10 (50.0%), respectively. Among the 41 CRP-negative patients tested, IL-6 and suPAR levels were always normal, while SAA was elevated in 17.1%. Pericarditis with normal CRP exhibits distinct clinical and laboratory features, often presenting with an incessant course. Although rarely elevated, SAA may help to identify inflammation beyond CRP.

9 September 2024 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
EBEmanuele Bizzi
Emanuele Bizzi
FCFrancesco Cavaleri
Francesco Cavaleri
RMRuggiero Mascolo
Ruggiero Mascolo
Edoardo ConteEdoardo Conte
Edoardo Conte
SMStefano Maggiolini
Stefano Maggiolini
MIMassimo Imazio
Massimo Imazio
Background: Current guidelines for the diagnosis and treatment of pericarditis refer to the general adult population. Few and fragmentary data regarding recurrent pericarditis in older adults exist. Objective of the Study: Given the absence of specific data in scientific literature, we hypothesized that there might be clinical, laboratory and outcome differences between young adults and older adults affected by idiopathic recurrent pericarditis. Materials and Methods: We performed an international multicentric retrospective cohort study analyzing data from patients affected by recurrent pericarditis (idiopathic or post‐cardiac injury) and referring to tertiary referral centers. Clinical, laboratory, and outcome data were compared between patients younger than 65 years (controls) and patients aged 65 or older. Results: One hundred and thirty‐three older adults and 142 young adult controls were enrolled. Comorbidities, including chronic kidney diseases, atrial fibrillation, and diabetes, were more present in older adults. The presenting symptom was dyspnea in 54.1% of the older adults versus 10.6% in controls ( p < 0.001); pain in 32.3% of the older adults versus 80.3% of the controls ( p < 0.001). Fever higher than 38°C was present in 33.8% versus 53.5% ( p = 0.001). Pleural effusion was more prevalent in the older adults (55.6% vs 34.5%, p < 0.001), as well as severe pericardial effusion (>20 mm) (24.1% vs 12.7%, p = 0.016) and pericardiocentesis (16.5% vs 8.5%, p = 0.042). Blood leukocyte counts were significantly lower in the older adults (mean + SE: 10,227 + 289/mm 3 vs 11,208 + 285/mm 3 , p = 0.016). Concerning therapies, NSAIDS were used in 63.9% of the older adults versus 80.3% in the younger ( p = 0.003), colchicine in 76.7% versus 87.3% ( p = 0.023), corticosteroids in 49.6% versus 26.8% ( p < 0.001), and anakinra in 14.3% versus 23.9% ( p = 0.044). Conclusions: Older adults affected by recurrent pericarditis show a different clinical pattern, with more frequent dyspnea, pleural effusion, severe pericardial effusion, and lower fever and lower leukocyte count, making the diagnosis sometimes challenging. They received significantly less NSAIDs and colchicine, likely due to comorbidities; they were also treated less commonly with anti‐IL1 agents, and more frequently with corticosteroids.

20 August 2024 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
AMAngela Mauro
Angela Mauro
EBEmanuele Bizzi
Emanuele Bizzi
Maddalena Alessandra WuMaddalena Alessandra Wu
Maddalena Alessandra Wu
RMRuggiero Mascolo
Ruggiero Mascolo
CCCamilla Chirico
Camilla Chirico
ABAntonio Brucato
Antonio Brucato